Safety and tolerability of recombinant human parathyroid hormone (rhPTH[1-84]) in a randomized, double-blind, placebo-controlled study for the treatment of adults with hypoparathyroidism

Authors
Category Primary study
JournalEndocrine Reviews
Year 2012
This article has no abstract
Epistemonikos ID: 701cbbdda3f8bff2682945064530ed4590b9a3d5
First added on: Feb 05, 2025